Takeda Delivers Strong First Quarter FY2022 Results; On Trac

Press release content from Business Wire. The AP news staff was not involved in its creation.

Related Keywords

Japan , Australia , Osaka , United States , United Kingdom , China , South Korea , Switzerland , American , Demyelinating Polyradiculoneuropathy , Megan Ostrower , Jun Saito , Christopher Oreilly , International Financial Reporting Standards , American Society Of Clinical Oncology , Momenta Pharmaceuticals Inc , Takeda Pharmaceutical Company , Exchange Commission , Arrowhead Pharmaceuticals , European Union , Takeda Pharmaceutical Company Limited , Constant Exchange Rate , Johnson , Costa Saroukos , Launch Products , Free Cash Flow , Derived Therapies , Authorization Application , Northern European Conference , Travel Medicine , New England Journal , Breakthrough Therapy Designation , Orphan Drug Designation , American Society , Clinical Oncology , Annual Meeting , Momenta Pharmaceuticals , Rare Genetic , Plasma Derived Therapies , Annual Report , Score Revenue , Core Operating Profit , Core Net Profit , Net Debt , Free Cash , Business Wire , Covid 19 , Health , Business ,